Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer

Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer

Identification of early-stage tumor and monitoring therapeutic efficacy and recurrence or metastasis of colorectal cancer (CRC) are urgently warranted for improving the outcome of CRC patients and reducing the disease-related mortality. In this study, we evaluated the diagnostic value of cell-free c...

Full description

Bibliographic Details
Main Authors:	Bo Fu, Peng Yan, Shan Zhang, Yan Lu, Li Pan, Wenqiang Tang, Shen Chen, Shuangfeng Chen, Anqi Zhang, Wei Liu
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Disease Markers
Online Access:	http://dx.doi.org/10.1155/2018/6437104

Similar Items

SEPT9 Gene Methylation as a Noninvasive Marker for Hepatocellular Carcinoma
by: Baoliang Li, et al.
Published: (2020-01-01)

The role of mSEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer
by: Jie Sun, et al.
Published: (2019-05-01)

Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer
by: Yi Liu, et al.
Published: (2020-04-01)

Role of blood mSEPT9 in evaluating tumor burden and disease monitoring in colorectal cancer patients
by: Chen, X., et al.
Published: (2021)

Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection
by: Guodong Zhao, et al.
Published: (2020-06-01)

Identification of a new methylation site in the Sept9 promoter region for the diagnosis of hepatocellular carcinoma
by: N. L. Lazarevich, et al.
Published: (2019-12-01)

Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma
by: Abderrahim Oussalah, et al.
Published: (2018-04-01)

Utility of the methylated SEPT9 test for the early detection of colorectal cancer: a systematic review and meta-analysis of diagnostic test accuracy
by: Rohit Hariharan, et al.
Published: (2020-11-01)

Diagnostic Value of Methylated Septin9 for Colorectal Cancer Detection
by: Li Xie, et al.
Published: (2018-07-01)

Analysis of SEPT9 Gene Promoter Methylation Status in Esophageal Squamous Cell Carcinoma
by: Aida Mirza Aghasi, et al.
Published: (2020-01-01)

Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.
by: Marc Tänzer, et al.
Published: (2010-02-01)

Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.
by: Kinga Tóth, et al.
Published: (2014-01-01)

The role of p53 in SEPT9 regulation
by: McKee, K. A.
Published: (2012)

Alternative splicing of sept9a and sept9b in zebrafish produces multiple mRNA transcripts expressed throughout development.
by: Megan L Landsverk, et al.
Published: (2010-05-01)

Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker
by: Gloria Ravegnini, et al.
Published: (2015-12-01)

Independent regulation and function of SEPT9 splice variants
by: Matchett, Kyle Brian
Published: (2010)

Characterisation of SEPT9 gene expression in health and disease
by: Scott, M.
Published: (2004)

Novel Liquid Biopsy Test Based on a Sensitive Methylated SEPT9 Assay for Diagnosing Hepatocellular Carcinoma
by: Yurika Kotoh, et al.
Published: (2020-03-01)

Cell-Free Nucleic Acids As Noninvasive Biomarkers For Colorectal Cancer Detection
by: Hicham eMansour
Published: (2014-08-01)

The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis
by: Lele Song, et al.
Published: (2017-06-01)

Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.
by: Dimo Dietrich, et al.
Published: (2013-01-01)

Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers.
by: Kinga Tóth, et al.
Published: (2012-01-01)

Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis
by: Xianyu Zhang, et al.
Published: (2021-08-01)

Methylation of cell-free circulating DNA in the diagnosis of cancer
by: Goli eSamimi, et al.
Published: (2015-04-01)

ThE uSE of AbErrAnT METhylATEd gEnES SEPT9 And VIM for clInIcAl dIAgnoSIS of colorEcTAl cAncEr
by: O I Brovkina, et al.
Published: (2016-12-01)

An Interaction Network of the Human SEPT9 Established by Quantitative Mass Spectrometry
by: Matthias Hecht, et al.
Published: (2019-06-01)

Noninvasive prediction of response to cancer therapy using promoter profiling of circulating cell‐free DNA
by: Zhi‐Wei Guo, et al.
Published: (2020-09-01)

Estudos estruturais da SEPT8 e análise de suas interações com SEPT5 e SEPT7
by: Sinara Teixeira do Brasil Morais
Published: (2014)

Estudos estruturais da SEPT8 e análise de suas interações com SEPT5 e SEPT7
by: Morais, Sinara Teixeira do Brasil
Published: (2014)

Sept 4.03
by: Jeffrey Filbert
Published: (2006-01-01)

Meeting Sept. 3.
Published: ()

Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1.
by: Dikla Vardi-Oknin, et al.
Published: (2013-01-01)

Molecular Alterations in Circulating Cell-Free DNA in Patients with Colorectal Adenoma or Carcinoma
by: Hu Y, et al.
Published: (2020-06-01)

A 3-circular RNA signature as a noninvasive biomarker for diagnosis of colorectal cancer
by: Dao-xiong Ye, et al.
Published: (2019-11-01)

Circulating cell-free DNA as a biomarker in the diagnosis and prognosis of colorectal cancer
by: Isadora Bernardo David de Oliveira, et al.
Published: (2018-06-01)

RECL 219 - Sept. 1983
Published: (2011)

RELC 308 - Sept. 1982
Published: (2011)

RECL 314 - Sept. 1982
Published: (2011)

RECL 151 - Sept./83
Published: (2011)

RECL 152 - Sept./83
Published: (2011)